Package Leaflet: Information for the User
Arimidex 1 mg Film-Coated Tablets
Anastrozole
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
Arimidex contains a substance called anastrozol and belongs to a group of medications known as “aromatase inhibitors”. Arimidex is used to treat breast cancer in women who are in menopause.
Arimidex acts by reducing the amount of hormones called estrogens that are produced by your body, by blocking a natural bodily substance (an enzyme) called “aromatase”.
Do not take Arimidex
Do not take Arimidex if you find yourself in any of the situations described above. If you are unsure, consult your doctor or pharmacist before taking Arimidex.
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to take Arimidex.
If you are unsure whether any of this affects you, consult your doctor or pharmacist before taking Arimidex.
Inform hospital staff that you are taking Arimidex if you are admitted to the hospital.
Taking Arimidex with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication. This includes medications you purchase without a prescription and herbal remedies. This is because Arimidex may affect the activity of other medications, and some medications may have an effect on Arimidex.
Do not take Arimidex if you are already being treated with any of the following medications:
If you find yourself in any of these situations, seek advice from your doctor or pharmacist.
Inform your doctor or pharmacist if you are taking the following:
Pregnancy and breastfeeding
Do not take Arimidex if you are pregnant or breastfeeding. Discontinue Arimidex if you become pregnant and consult your doctor.
Consult your doctor or pharmacist before using any medication.
Driving and operating machinery
It is unlikely that Arimidex will affect your ability to drive or use any tools or machinery. However, some patients may occasionally feel weakness or drowsiness while taking Arimidex. If this happens to you, seek advice from your doctor or pharmacist.
Arimidex contains lactose
Arimidex contains lactose, a type of sugar. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Arimidex contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially “sodium-free”.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Continue taking Arimidex for the time your doctor or pharmacist tells you to. This is a long-term treatment and you may need to take it for several years. In case of doubt, consult your doctor or pharmacist.
Use in children and adolescents
Arimidex should not be administered to children and adolescents.
If you take more Arimidex than you should
If you take more Arimidex than you should, contact your doctor immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service. Phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Arimidex
If you forget to take a dose, simply take the next dose normally.
Do not take a double dose (two doses at the same time) to make up for the missed doses.
If you interrupt treatment with Arimidex
Do not stop taking your tablets unless your doctor tells you to.
If you have any other questions about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Stop taking Arimidex and seek urgent medical treatment if you experience any of the following severe but rare side effects:
Very common side effects may affect more than 1 in 10 people
Common side effects may affect up to 1 in 10 people
Rare side effects may affect up to 1 in 100 people
Rare side effects may affect up to 1 in 1,000 people
Effects on your bones
Arimidex reduces the levels of hormones called estrogens present in your body. This can reduce the mineral content of your bones. They may be less strong and make fractures more likely. Your doctor will monitor these risks according to the treatment guidelines for bone health in postmenopausal women. You should talk to your doctor about the risks and treatment options.
If you consider any of the side effects you are experiencing to be severe or if you notice any side effect not mentioned in this prospectus, report to your doctor or pharmacist.
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this prospectus. You can also report them directly through the Spanish System of Pharmacovigilance of Medicines for Human Use https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Do not store above 86°F (30°C).
Keep this medication out of the sight and reach of children. Store the tablets in a safe place where children cannot see or reach them. Your tablets could harm them.
Do not use this medication after the expiration date that appears on the packaging and on the blister pack after CAD. The expiration date is the last day of the month indicated.
Store in the original packaging.
Medications should not be disposed of through drains or in the trash. Deposit the containers and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
Arimidex Composition
Appearance of the product and contents of the pack
White, round, biconvex film-coated tablets, approximately 6.1 mm in size, marked with a “A” on one face and 'Adx1' on the other.
Arimidex is presented in blister packs containing 28 tablets.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
Juvisé Pharmaceuticals
149 boulevard Bataille de Stalingrad
69100 Villeurbanne
France
Responsible manufacturer
Haupt Pharma Muenster GmbH
Schleebrueggenkamp 15, Muenster
Nordrhein-Westfalen 48 159
Germany
AstraZeneca AB
Gärtunavägen
SE-151 85 Södertälje
Sweden
This medicine is authorized in the member states of the European Economic Area with the following names:
Germany: Arimidex
Austria: Arimidex
Belgium: Arimidex
Bulgaria: Arimidex
Cyprus: Arimidex
Denmark: Arimidex
Slovenia: Arimidex 1mg filmsko obložene tablete
Spain: Arimidex 1 mg comprimidos recubiertos con película
Estonia: Arimidex
Finland: Arimidex
France: Arimidex
Greece: Arimidex
Netherlands: Arimidex
Hungary: Arimidex
Iceland: Arimidex
Ireland: Arimidex
Italy: Arimidex
Latvia: Arimidex
Lithuania: Arimidex
Luxembourg: Arimidex
Malta: Arimidex
Norway: Arimidex
Poland: Arimidex
Portugal: Arimidex
United Kingdom: Arimidex
Czech Republic: Arimidex
Slovakia: Arimidex
Romania: Arimidex
Sweden: Arimidex
Last review date of this leaflet:September 2021
Other sources of information
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.